195 related articles for article (PubMed ID: 2334450)
1. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activity.
Safak C; Erdemli I; Sunal R
Arzneimittelforschung; 1993 Oct; 43(10):1052-5. PubMed ID: 8267668
[TBL] [Abstract][Full Text] [Related]
3. 3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities.
Safak C; Ozkanli F; Erol K; Aktan Y
Arzneimittelforschung; 1995 Nov; 45(11):1154-6. PubMed ID: 8929229
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
Inglesi M; Nicola M; Magnetti S
Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3.
Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B
Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.
Zarghi A; Derakhshandeh K; Roshanzamir F; Jorjani M; Rastegar H; Varmazyari M; Shafiee A
Boll Chim Farm; 2002; 141(1):15-20. PubMed ID: 12064052
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
[TBL] [Abstract][Full Text] [Related]
10. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
Soldatov NM
Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of alkyl 2,6-dimethyl-(substituted or unsubstituted furyl)-1,4-dihydropyridine-3,5-dicarboxylates].
Zhang YH; Zhang ZQ; Wu Q
Yao Xue Xue Bao; 1991; 26(5):375-8. PubMed ID: 1957689
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, chemical and pharmacological properties of some 4-aryl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-diones.
Saraç S; Yarim M; Ertan M; Boydağ S; Erol K
Pharmazie; 1998 Feb; 53(2):91-4. PubMed ID: 9540105
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
Navidpour L; Miri R; Shafiee A
Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
15. [Calcium modulators of the anellated dihydropyridine type. Synthesis and pharmacologic action].
Rose U
Arzneimittelforschung; 1989 Nov; 39(11):1393-8. PubMed ID: 2619769
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the Ca2+-antagonistic activity of some Bulgarian vasodilating agents and of known Ca2+-antagonists on K+-depolarized smooth muscle from guinea-pig taenia coli.
Mutafova-Yambolieva V; Staneva-Stoytcheva D; Nikolov R
Acta Physiol Pharmacol Bulg; 1989; 15(2):40-6. PubMed ID: 2801147
[TBL] [Abstract][Full Text] [Related]
17. Ca-antagonistic activity of some 1,4-piperazine derivatives.
Seginko J; Dobrocký P; Cagánová B
Pharmazie; 1995 May; 50(5):368-9. PubMed ID: 7604073
[No Abstract] [Full Text] [Related]
18. Synthesis and calcium antagonistic activity of 2,6,6-trimethyl-3-carbomethoxy(ethoxy)-4-aryl-1,4,5,6,7,8-hexahydroquinoline derivatives.
Simşek R; Ismailoğlu UB; Safak C; Sahin-Erdemli I
Farmaco; 2000; 55(11-12):665-8. PubMed ID: 11204940
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
